Abstract
Many of the ethical issues raised by clinical trials in multiple sclerosis (MS) are no different from those that arise in clinical research in other diseases. They are the basic ethical problems of the conduct of research on human subjects, more specifically, the problems of research on ill and vulnerable human subjects.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Annas GJ, Grodin MA (1992) The Nazi doctors and the Nuremberg Code. Oxford University Press, New York, pp 102–103,331–342 x
Beecher HK (1966) Ethics and clinical research. N Engl J Med 274: 1354–1360
Clinical Research Subcommittee of the Scientific Issues Committee, American Academy of Neurology (1995) Status of clinical research in neurology. Neurology 45: 839–845
Confavreaux C, Paty D (1995) Current status of computerization of multiple sclerosis clinical data for research in Europe and North America: the EDMUS/MS-COSTAR connection. Neurology 45: 573–576
Curran WJ (1973) The Tuskegee syphilis study. N Engl J Med 289: 730–731
Emanuel E, Steiner D (1995) Institutional conflicts of interest. N Engl J Med 332: 262–267
Fischl MA, Richman DD, Grieco MH et al. (1987) The efficacy of azidothymidine ( AZT) in the treatment of patients with AIDS and AIDS-related complex. N Engl J Med 317: 185–191
Freedman B (1987) Equipoise and the ethics of clinical research. N Engl J Med 317: 141–145
Goodkin D, Kanoti G (1994) Ethical considerations raised by the approval of interferon beta-lb for the treatment of multiple sclerosis. Neurology 44: 166–170
IFNB Multiple Sderosis Study Group (1993) Interferon beta-lb is effective in relapsing-remitting multiple sclerosis: I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43: 655–661
Kampmeier RH (1972) The Tuskegee study of untreated syphilis. South Med J 65:1247–1251 Kampmeier RH (1974) Final report on the “Tuskegee Syphilis Study”. South Med J 67:1349–1353 Katz J (1993) “Ethics and clinical research” revisited: a tribute to Henry K. Beecher. Hastings Cent Rep 23 (5): 31–39
Munson R.(ed) (1992) Intervention and reflection: basic issues in medical ethics, 4th edn. Wadsworth, Belmont, CA, pp 392–394
Noseworthy J, Ebers G, Vandervoort M, Farquhar R, Yetisir E, Roberts R (1994) The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. Neurology 44: 16–20
Rothman DJ (1987) Ethics and human experimentation. N Engl J Med 317: 1195–1199
Rothman KJ, Michels KB (1994) The continuing unethical use of placebo controls. N Engl J Med 331: 394–398
Spilker B (1991) Guide to clinical trials. Raven Press, New York, pp 124–128
Volberding PA, Lagakos SW, Koch MA et al. (1990) Zidovudine in asymptomatic human immunodeficiency virus infection. N Engl J Med 322: 941–949
Whitaker JN, McFarland HF, Rudge P, Reingold, SC (1995) Outcomes assessment in multiple sclerosis clinical trials: a critical analysis. Multiple Sclerosis 1: 37–47
Wittes, J (1994) Monitoring clinical trials: relationships among data monitoring board, sponsor, and investigators [Abstract]. In: Outcomes assessment in multiple sclerosis clinical trials: a critical analysis. A Meeting of the National Multiple Sclerosis Society; 1994 Feb; Charleston, SC
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag London Limited
About this chapter
Cite this chapter
Foa, R. (1996). Ethical Considerations Raised by Clinical Trials. In: Goodkin, D.E., Rudick, R.A. (eds) Multiple Sclerosis. Springer, London. https://doi.org/10.1007/978-1-4471-1271-6_15
Download citation
DOI: https://doi.org/10.1007/978-1-4471-1271-6_15
Publisher Name: Springer, London
Print ISBN: 978-1-85233-033-0
Online ISBN: 978-1-4471-1271-6
eBook Packages: Springer Book Archive